EUVIMED · CrossrefJournal
Journal of Sickle Cell Disease
ISSN 3029-0473 · Oxford University Press (OUP)
Latest articles
Exploring Patient Satisfaction among Pediatric Patients with Sickle Cell Disease: A Qualitative Study
Welcome Letter
Efficacy and safety of osivelotor in participants with sickle cell disease in a 12-week, phase 2, multicenter, open-label, dose-finding trial and extension study
Retinal Optical Coherence Tomography as a Noninvasive Biomarker of Silent Cerebral Infarcts in Pediatric Sickle Cell Disease
Neuroimmune signaling through spinal IL-17–TNF-α/p38 MAPK drives acute pain in sickle cell disease
Sickle cell disease: mechanisms underlying acute pain
A Youth-Led Community Recruitment Model to Increase Antigen-Matched Blood Availability for Sickle Cell Disease Patients in North Texas
Accelerating access to gene therapy: Lessons from commercial implementation in sickle cell disease and transfusion-dependent thalassemia
In Utero Cannabinoid Exposure Exacerbates Hyperalgesia in Offspring of Sickle Mice
HIBISCUS 2 (Trial-in-Progress): A Global, Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Etavopivat in Adolescents and Adults with Sickle Cell Disease
Safety and efficacy of pociredir in adults with severe sickle cell disease and hydroxyurea intolerance or unresponsiveness: results from the phase 1b PIONEER study
Secretory phospholipase A2 (sPLA2) during vaso-occlusive pain episodes (VOE) and acute chest syndrome (ACS) in sickle cell disease (SCD): results from a prospective multi-center randomized controlled trial (RCT)
Patient-Specific Modeling Reveals Stroke-Related Cerebral Hemodynamic Changes in Adults With Sickle Cell Disease
Emergency Department Leave Against Medical Advice Among Adults with Sickle Cell Disease: An Equity-Sensitive Indicator of System Performance
Psychosocial Mediators of the Fatigue–Pain Relationship in Adolescents with Sickle Cell Disease
Behavioral Health, Biological Complications, and Hospital Utilization in Adults With Sickle Cell Disease: Limits of Statewide Administrative Data
Association of transplant outcome and clonal hematopoiesis with baseline bone marrow cellularity and fibrosis in patients with sickle cell disease undergoing non-myeloablative allogeneic hematopoietic cell transplantation
Exagamglogene autotemcel (Exa-Cel) gene therapy for sickle cell disease: a multicenter retrospective analysis using data from SCDC, ASH-RC, NHDR, and HCUP, benchmarked against CLIMB trial benchmarks
Venous Thromboembolism in Sickle Cell Crisis: Trends and Impact on Mortality and Length of Stay in Florida, 2020–2023
The SickleFit Exercise Pilot Study for older adults with sickle cell disease: feasibility, safety, and acceptability
Geographic Heat Vulnerability Among Individuals with Sickle Cell Disease: A Spatial Linkage Analysis
Narrative-based Decision-making: Co-development of a Graphic Educational Aid for Sickle Cell Disease Treatment Options
Mechanistic Dissection of VLA-4 Function in Sickle Reticulocytes Using Conformation-Sensitive Flow Cytometry and Shear-Based Adhesion
Associations Between Dietary Fat Intake, Pain, and Interleukin-10 Levels in Adults with Steady-State Sickle Cell Disease
Etavopivat in Adolescents with Sickle Cell Disease: Emerging Safety and Efficacy Findings from the First Cohort of the Ongoing Phase 1/2 HIBISCUS Kids Study
Social Vulnerability Index Factors Related to Socioeconomic Status and Access to Care Among Adults Living with Sickle Cell Disease
Using Electronic-Medical Records to Facilitate Transition From Pediatric to Adult Hematology for Sickle Cell Disease
Equity Tools Miss High-Burden Pediatric Diseases: Sickle Cell Disease in New York City Community Health
Reducing Provider Stigma in Sickle Cell Disease Through a Community-Led Intervention Across Clinical Settings
Long Term Anticoagulation for Venous Thromboembolism in Sickle Cell Disease: A Systematic Review (1995–December 2025)
EUVIMED